ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 108 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2021. The put-call ratio across all filers is 28.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,321 | +15.7% | 4,100 | 0.0% | 0.00% | – |
Q1 2023 | $2,870 | -0.9% | 4,100 | 0.0% | 0.00% | – |
Q4 2022 | $2,895 | +189.5% | 4,100 | +1071.4% | 0.00% | – |
Q3 2022 | $1,000 | – | 350 | 0.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 350 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -50.0% | 350 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | -33.3% | 350 | -22.2% | 0.00% | – |
Q3 2021 | $3,000 | -25.0% | 450 | -10.0% | 0.00% | – |
Q2 2021 | $4,000 | -100.0% | 500 | -50.0% | 0.00% | – |
Q1 2021 | $8,320,000 | +207900.0% | 1,000 | +100.0% | 0.00% | – |
Q4 2020 | $4,000 | -20.0% | 500 | 0.0% | 0.00% | – |
Q3 2020 | $5,000 | -37.5% | 500 | 0.0% | 0.00% | – |
Q2 2020 | $8,000 | +100.0% | 500 | 0.0% | 0.00% | – |
Q1 2020 | $4,000 | -50.0% | 500 | 0.0% | 0.00% | – |
Q4 2019 | $8,000 | -11.1% | 500 | 0.0% | 0.00% | – |
Q3 2019 | $9,000 | -18.2% | 500 | 0.0% | 0.00% | – |
Q2 2019 | $11,000 | 0.0% | 500 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $11,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $11,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 2,065,560 | $39,638,000 | 23.01% |
Selkirk Management LLC | 165,700 | $3,180,000 | 1.90% |
Opaleye Management Inc. | 100,000 | $1,919,000 | 0.97% |
LUCUS ADVISORS LLC | 80,000 | $1,535,000 | 0.68% |
Miura Global Management | 435,000 | $8,348,000 | 0.63% |
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 276,549 | $5,307,000 | 0.48% |
Iguana Healthcare Management, LLC | 50,000 | $960,000 | 0.46% |
BSW Wealth Partners | 22,714 | $436,000 | 0.35% |
Harvest Capital Strategies LLC | 90,000 | $1,727,000 | 0.19% |
FAIRFIELD, BUSH & CO. | 35,100 | $674,000 | 0.19% |